Singapore markets closed

Straits Times Index
3,331.70
+5.42(+0.16%)
S&P 500
5,469.30
+21.43(+0.39%)
Dow
39,112.16
-299.05(-0.76%)
Nasdaq
17,717.65
+220.84(+1.26%)
Bitcoin USD
61,360.52
+162.90(+0.27%)
CMC Crypto 200
1,275.32
-8.46(-0.66%)

RMD Jun 2024 220.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

10.10

+1.91

(+23.32%)

As of 03:06PM EDT. Market open.

Loading interactive chart…

Zacks
Medtronic (MDT) Shares Positive Data for MiniMed 780G System
Medtronic (MDT) presents more compelling data showcasing the benefits of the MiniMed 780G system.
Barrons.com
It's Not Just a Bad Day for Chip Stocks. ResMed Is the S&P 500’s Top Decliner.
ResMed stock was the worst performer in the S&P 500 Monday as Eli Lilly’s weight-loss medicine showed signs of reducing sleep apnea. Lilly said its medication tirzepatide, sold under the brand names Mounjaro and Zepbound, reduced obstructive sleep apnea severity by up to 62.8%. ResMed sells CPAP machines that treat sleep apnea, so this news was not a good sign for investors.
Yahoo Finance
How Lilly is joining Novo in the crusade to circumvent Medicare's block on weight loss drugs
The leaders in the business of weight-loss drugs, Novo Nordisk and Eli Lilly, are fighting on a number of fronts to get Medicare officials to pay for the popular medicines.